|Articles|June 1, 1999

Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
Volume 5
Issue 8 Suppl

Methotrexate Therapy in the Year 2000: Outstanding Questions

Author(s)Michael E. Weinblatt, MD

Download PDF: Methotrexate Therapy in the Year 2000: Outstanding Questions

Articles in this issue

about 27 years ago

Article

Participating Faculty

about 27 years ago

Article

Introduction

about 27 years ago

Article

Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis

about 27 years ago

Article

State-of-the-Art Combination Therapy in 1999

about 27 years ago

Article

Assessing New Therapies for RA: Defining New Expectations for Treatment; New Therapies in Clinical Practice: Issues of Cost and Access

about 27 years ago

Article

The Emerging Role of Anti-TNF Therapy in the Treatment of Rheumatoid Arthritis

about 27 years ago

Article

Selected Abstracts

about 27 years ago

Article

CME Quiz

about 27 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Methotrexate Therapy in the Year 2000: Outstanding Questions

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

Health Equity & Access Weekly Roundup: June 26, 2026

FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer

ATTR-CM Incidence, Prevalence Rose Sharply in the US